Vertebral fractures cascade: potential causes and risk factors

Osteoporos Int. 2019 Mar;30(3):555-563. doi: 10.1007/s00198-018-4793-1. Epub 2018 Dec 5.

Abstract

We performed a study to identify potential causes and risk factors of vertebral fracture cascade. Vertebral fracture cascade is a severe clinical event in patients with bone fragility. Only half of patients have an identified cause of secondary osteoporosis.

Introduction: Vertebral fracture (VF) is the most common osteoporotic fracture, and a strong risk factor of subsequent VFs leading to VF cascade (VFC). We prompted a study to identify potential causes and risk factors of VFC.

Methods: VFC observations were collected retrospectively between January 2016 and April 2017. VFC was defined as an occurrence of at least three VFs within 1 year.

Results: We included in 10 centers a total of 113 patients with VFC (79.6% of women, median age 73, median number of VFs in the cascade, 5). We observed 40.5% and 30.9% of patients with previous major fractures and a previous VF, respectively, and 68.6% with densitometric osteoporosis; 18.9% of patients were currently receiving oral glucocorticoids and 37.1% in the past. VFC was attributed by the physician to postmenopausal osteoporosis in 54% of patients. A secondary osteoporosis associated with the VFC was diagnosed in 52 patients: glucocorticoid-induced osteoporosis (25.7%), non-malignant hemopathies (6.2%), alcoholism (4.4%), use of aromatase inhibitors (3.6%), primary hyperparathyroidism (2.7%), hypercorticism (2.7%), anorexia nervosa (2.7%), and pregnancy and lactation-associated osteoporosis (1.8%). A total of 11.8% of cases were reported following a vertebroplasty procedure. A total of 31.5% patients previously received an anti-osteoporotic treatment. In six patients, VFC occurred early after discontinuation of an anti-osteoporotic treatment, in the year after the last dose effect was depleted: five after denosumab and one after odanacatib.

Conclusion: The results of this retrospective study showed that only half of VFC occurred in patients with a secondary cause of osteoporosis. Prospective studies are needed to further explore the determinants of this severe complication of osteoporosis.

Keywords: Cascade; Osteoporosis; Risks factors; Vertebral fractures.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Density Conservation Agents / therapeutic use
  • Female
  • France / epidemiology
  • Glucocorticoids / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis / complications
  • Osteoporosis / drug therapy
  • Osteoporosis / epidemiology
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / drug therapy
  • Osteoporosis, Postmenopausal / epidemiology
  • Osteoporotic Fractures / epidemiology
  • Osteoporotic Fractures / etiology*
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Spinal Fractures / epidemiology
  • Spinal Fractures / etiology*

Substances

  • Bone Density Conservation Agents
  • Glucocorticoids